Stockreport

Appendix 4C – Q1 FY25 Quarterly Cash Flow Report

Alterity Therapeutics Limited - American Depositary Shares  (ATHE) 
PDF Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for release in January 2025Positive interim data reported from ATH434-20 [Read more]